| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.0075 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.00099 | 1 |